| Association of pathologic complete response with long-term survival outcomes in triple-negative breast cancer: a meta-analysis M Huang, J O'Shaughnessy, J Zhao, A Haiderali, J Cortés, SD Ramsey, ... Cancer Research 80 (24), 5427-5434, 2020 | 97 | 2020 |
| Estimation of causal effects of multiple treatments in observational studies with a binary outcome L Hu, C Gu, M Lopez, J Ji, J Wisnivesky Statistical methods in medical research 29 (11), 3218-3234, 2020 | 64 | 2020 |
| Evaluation of pathologic complete response as a surrogate for long-term survival outcomes in triple-negative breast cancer M Huang, J O’Shaughnessy, J Zhao, A Haiderali, J Cortes, S Ramsey, ... Journal of the National Comprehensive Cancer Network 18 (8), 1096-1104, 2020 | 37 | 2020 |
| Estimation of causal effects of multiple treatments in healthcare database studies with rare outcomes L Hu, C Gu Health Services and Outcomes Research Methodology, 1-22, 2021 | 16 | 2021 |
| A flexible sensitivity analysis approach for unmeasured confounding with multiple treatments and a binary outcome with application to SEER-Medicare lung cancer data L Hu, J Zou, C Gu, J Ji, M Lopez, M Kale The annals of applied statistics 16 (2), 1014, 2022 | 14 | 2022 |
| Evaluation of pathological complete response as a trial-level surrogate for long-term survival outcomes among triple-negative breast cancer patients receiving neoadjuvant therapy M Huang, CZ Qi, S Ramsey, A Briggs, J Zhao, A Haiderali, V Karantza, ... Annals of Oncology 30, iii34-iii35, 2019 | 9 | 2019 |
| Combining item response theory with multiple imputation to equate health assessment questionnaires C Gu, R Gutman Biometrics 73 (3), 990-998, 2017 | 9 | 2017 |
| Angiotensinogen promoter polymorphisms predict low diffusing capacity in US and Spanish IPF cohorts MTT Dang, C Gu, JI Klavanian, KA Jernigan, KH Friderici, Y Cui, ... Lung 191, 353-360, 2013 | 6 | 2013 |
| Triple-negative breast cancer M Huang, J O'Shaughnessy, J Zhao, A Haiderali, J Cortés, SD Ramsey, ... | 4 | 2021 |
| Meta-analysis on association of pathological complete response with long-term survival outcomes in triple-negative breast cancer PA Fasching, M Huang, J Cortés, J Zhao, J O’Shaughnessy, P Hu, ... Annals of Oncology 30, v80, 2019 | 4 | 2019 |
| DEVELOPMENT OF A COMMON PATIENT ASSESSMENT SCALE ACROSS THE CONTINUUM OF CARE C Gu, R Gutman The Annals of Applied Statistics 13 (1), 466-491, 2019 | 4 | 2019 |
| 1390P Evaluation of event-free survival as a trial-level surrogate for overall survival for patients with gastric and gastroesophageal junction adenocarcinoma in neoadjuvant … J Xie, A Valderrama, L Yin, S Zhang, CS Shih, C Gu, P Bhagia, ... Annals of Oncology 32, S1052-S1053, 2021 | | 2021 |
| A Bayesian hierarchical model for characterizing the diffusion of new antipsychotic drugs C Gu, H Huskamp, J Donohue, SL Normand Biometrics 77 (2), 649-660, 2021 | | 2021 |
| PCN266 ONCOLOGY SEQUENCE MODELS IN HEALTH TECHNOLOGY ASSESSMENT-A LITERATURE REVIEW W Xue, M Huang, SD Ramsey, C Gu, J Xie, E Wu, J Pellissier, A Briggs Value in Health 23, S69-S70, 2020 | | 2020 |
| Association of Pathological Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-analysis V Karantza, G Aktan, CZ Qi, C Gu, J Xie, M Yuan, J Cook, M Untch, ... | | |
